Trial intelligence / Profile preview

Low Dose Parenteral Fat for PNAC Prevention in Neonates

NCT01373918Phase 4Terminated

Sponsor
University of California, Los Angeles
Start
Dec 2010
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Intralipid 10% in parenteral nutrition-associated cholestasis (PNAC), sponsored by University of California, Los Angeles. Started Dec 2010; status: terminated.

02

Drugs

Intralipid 10%
03

Conditions

parenteral nutrition-associated cholestasis (PNAC)

Beyond the preview

Go deeper on NCT01373918.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01373918.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call